The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells.
Saved in:
| Title: | The retinoid X receptor agonist bexarotene (Targretin) synergistically enhances the growth inhibitory activity of cytotoxic drugs in non-small cell lung cancer cells. |
|---|---|
| Authors: | Hermann TW; Department of Molecular Oncology, Ligand Pharmaceuticals Inc., 10275 Science Center Drive, San Diego, CA 92121, USA., Yen WC, Tooker P, Fan B, Roegner K, Negro-Vilar A, Lamph WW, Bissonnette RP |
| Source: | Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2005 Oct; Vol. 50 (1), pp. 9-18. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8800805 Publication Model: Print Cited Medium: Print ISSN: 0169-5002 (Print) Linking ISSN: 01695002 NLM ISO Abbreviation: Lung Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
